These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 5004758)
21. Data on the lack of a particular myelotoxicity of chloramphenicol in Israel. Sheba C; Shani M Haematol Lat; 1969; 12(3):539-42. PubMed ID: 5396825 [No Abstract] [Full Text] [Related]
22. [Management of drug-induced agranulocytosis associated with severe septicemia]. Tornóczky J; Tóth A; Balikó Z; Kolumbusz L; Muth L; Kósa Z Orv Hetil; 1985 Jun; 126(22):1349-53. PubMed ID: 3925418 [No Abstract] [Full Text] [Related]
23. [On the epidemiology and clinical aspects of agranulocytosis caused by drug hypersensitivity]. Gross R; Horstmann H; Vogel J; Zach J Med Welt; 1967 Aug; 31():1767-79. PubMed ID: 6063250 [No Abstract] [Full Text] [Related]
24. Fatal agranulocytosis developed in the course of carbamazepine therapy. A case report and review of the literature. Olcay L; Pekcan S; Yalnizoğlu D; Büyükpamukçu M; Yalaz K Turk J Pediatr; 1995; 37(1):73-7. PubMed ID: 7732613 [TBL] [Abstract][Full Text] [Related]
29. [Agranulocytosis. Analysis of 29 episodes in 19 patients]. Ríos Sánchez I; Duarte L; Sánchez Medal L Rev Invest Clin; 1971; 23(1):29-42. PubMed ID: 5565270 [No Abstract] [Full Text] [Related]
30. [Clinical contributions to the problem of allergic encephalopathies]. Waitsuk P; Zakariás S; Becuş T; Gáspár S Stud Cercet Neurol; 1969; 14(3):183-7. PubMed ID: 4242072 [No Abstract] [Full Text] [Related]
31. Clinical examples of resolution of some idiopathic and other chronic disease by careful allergic management. Bryan WT; Bryan MP Laryngoscope; 1972 Jul; 82(7):1231-8. PubMed ID: 5078641 [No Abstract] [Full Text] [Related]
32. [Chloramphenicol (Chloracid)-allergy]. Korossy S; Vincze E; Gózony M Z Haut Geschlechtskr; 1966 Nov; 41(10):375-9. PubMed ID: 5997573 [No Abstract] [Full Text] [Related]
33. [Chloramphenicol panmyelopathy in a child]. Juchum W Wien Med Wochenschr; 1970 Jul; 120(30):536-42. PubMed ID: 5513642 [No Abstract] [Full Text] [Related]
34. Agranulocytosis during therapy with a brompheniramine-medication. Hardin AS; Padilla F J Ark Med Soc; 1978 Nov; 75(6):206-8. PubMed ID: 152746 [No Abstract] [Full Text] [Related]
35. Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases. Polak BC; Wesseling H; Schut D; Herxheimer A; Meyler L Acta Med Scand; 1972 Nov; 192(5):409-14. PubMed ID: 5083381 [No Abstract] [Full Text] [Related]
36. [Serum and leukocyte factors in agranulocytosis caused by hypersensitivity]. Pérez Miranda M; Pons F; del Real C; Bueno J; Ortiz de Landázuri E Rev Med Univ Navarra; 1971 Sep; 15(3):191-202. PubMed ID: 5152538 [No Abstract] [Full Text] [Related]
37. [Acute agranulocytosis as a result of probable hypersensitivity to the preparation cinnarizinum Polfa]. Szela S; Pozowska M; Lisik J; Kolan H; Krowińska W Wiad Lek; 1983 Sep; 36(18):1533-6. PubMed ID: 6666134 [No Abstract] [Full Text] [Related]
38. [Agranulocytosis as a result of an allergic cross reaction of procaine penicillin and meprobamate]. Nitzschner H Dtsch Gesundheitsw; 1967 Mar; 22(12):565-9. PubMed ID: 5593200 [No Abstract] [Full Text] [Related]
39. [Reversible allergic agranulocytosis due to ampicillin therapy]. Stille W Med Welt; 1969 Sep; 36():1981-4. PubMed ID: 5809877 [No Abstract] [Full Text] [Related]
40. [Schultz Agranulocytosis. A drug-allergy blood disease]. Hartl W Med Welt; 1971 Jun; 23():967-9. PubMed ID: 5579285 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]